Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid / Round Cell Liposarcoma
Sarcoma
Sarcoma
This is a study of genetically engineered ADP-A2M4 in HLA-A*02 subjects with metastatic or inoperable (advanced) Synovial Sarcoma or MRCLS who have received prior chemotherapy and whose tumor expresses the MAGE-A4 tumor antigen.
Sarcoma
II
Keedy, Vicki
NCT04044768
VICCSAR1948
